News
Lantern Pharma Fox Chase Cancer Center Collaborate on Advancing the Development of LP-184 in Pancreatic Cancer
Lantern Pharma , a clinical-stage biopharma company using its proprietary RADRยฎ artificial intelligence ("A.I.") platform to improve drug discovery & development and identify patients...
News
Serum Institute of India starts manufacturing Codagenix’s nasal COVID-19 vaccine
Serum Institute of India has started manufacturing COVID-19 vaccine candidate developed by Codagenix Inc, the US biotech firm said in a statement. Dubbed as...
News
Oxgene introduces TESSA technology for plasmid-free manufacturing system for Adeno-associated virus
Oxgene, a biotechnology company designing and developing scalable gene therapy technologies, has announced the launch of its scalable, plasmid-free manufacturing system for Adeno-associated virus...
Clinical Trials
Bharat Biotech to collaborate with Washington University School of Medicine on COVID-19 nasal vaccine
Vaccine maker Bharat Biotech has entered into an agreement with Washington University School of Medicine in St. Louis as part of which it will...
Clinical Trials
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate
Johnson & Johnson announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by...
Clinical Trials
I-Mab receives China NMPA clearance to begin phase 1 trial of lemzoparlimab in relapsed/refractory advanced lymphoma
I-Mab, a clinical stage biopharmaceutical company, announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has cleared...
News
US FDA grants fast track status to Gyroscope’s GT005 to treat dry age-related macular degeneration
Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, announced that the US FDA has granted Fast Track designation to GT005 for the treatment...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
















